Support Statement: This continuing medication activity is supported by Stryker.
Target Audience: The intended audience for this activity is plastic surgeons and other healthcare professionals involved in treatment of plastic surgery patients.
Learning Objectives:
Upon successful completion of this educational activity, participants should be better able to:
- Review the histological origin and the biological behavior of ameloblastoma in the mandible.
- Discuss the concept of customizing therapy for each patient with a Mandibular Ameloblastoma.
- Discuss the criteria for selecting the appropriate patient for FFF harvesting and mandibular reconstruction.
- Review the patient’s preoperative evaluation.
- Discuss the basic principles of using and manipulating the cornerstone in Head & Neck Reconstructive Surgery free flap, the Free Fibular Flap (FFF).
- Review the basic principles and the key steps in planning and harvesting in a safe way the FFF.
Faculty:
Harry D. Koumoullis M.D., D.D.S., M.Sc.
Resident (Specialty Registrar) of Plastic & Reconstructive Surgery at St. John's hospital
Resident (Specialty Registrar) Royal Hospital for Sick Children
Edinburgh, United Kingdom
Andreas Gravvanis, MD, PhD, FEBOPRAS
Department of Plastic Surgery–Microsurgery and Burn Center
General State Hospital of Athens
Athens, Greece
Dimitrios Anterriotis, DDS
Department of Oral & Maxillofacial Surgery
General State Hospital of Athens
Athens, Greece
Dimosthenis Tsoutsos MD, PhD
Department of Plastic Surgery–Microsurgery and Burn Center
General State Hospital of Athens
Athens, Greece
Nick Katsikeris DDS
Department of Oral & Maxillofacial Surgery
General State Hospital of Athens
Athens, Greece
External Reviewer:
Seth R. Thaller, MD, DMD, FACS
This enduring material is approved for 3 years from the date of release, December 8, 2014, to December 7, 2017.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Faculty member report the following relationship(s):
Harry D. Koumoullis M.D., D.D.S., M.Sc.
No relevant financial relationships to disclose.
Andreas Gravvanis, MD, PhD, FEBOPRAS
No relevant financial relationships to disclose.
Dimitrios Anterriotis, DDS
No relevant financial relationships to disclose.
Dimosthenis Tsoutsos MD, PhD
No relevant financial relationships to disclose.
Nick Katsikeris DDS
No relevant financial relationships to disclose.
External Reviewer reports the following relationship(s):
Seth R. Thaller, MD, DMD, FACS
No relevant financial relationships to disclose.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.